Skip to content

Optimal Flow Rate During Cardiopulmonary Bypass

Optimal Flow Rate During Cardiopulmonary Bypass

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01105078
Enrollment
60
Registered
2010-04-16
Start date
2010-05-31
Completion date
Unknown
Last updated
2014-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tissue Perfusion

Keywords

cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2

Brief summary

Regardless of the development of cardiac surgery techniques and technologies, the question of an optimal extracorporeal circulation is still unanswered. There are globally accepted standards of perfusion, however, keep many of these procedures was not evidence-based review. Generally accepted are flow rates during cardiopulmonary bypasses of 2.5 L/min/m2. This target was derived from the physiological conditions, but they are not the result of an adapted adjustment to the fundamentally non-physiological processes during extracorporeal circulation. Among other things, an increased metabolic demand during re-perfusion is not taken into account. An increasing and optimizing of the standard flow rate of 0.5 L/min/m2 should be the aim of this investigation. Under optimal perfusion, the investigators are maintaining the microcirculation and organ protection in receipt of endothelial function and oxygen transport.

Interventions

PROCEDUREFlow rate

Different flow rate during cardiopulmonary bypass

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Extracorporeal circulation * Age \> 18 * Written consent

Exclusion criteria

* Emergency cases

Design outcomes

Primary

MeasureTime frameDescription
Microcirulationintraooperativemeasurement with O2C

Countries

Germany

Contacts

Primary ContactArndt H Kiessling, MD
arndt.kiessling@kgu.de+49696301

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026